Companies in #DNA Immunotherapy
Found 1 company operating in this sector.
Scancell Holdings plc (LSE: SCLP) is a clinical-stage immuno-oncology company developing novel cancer vaccines and T-cell receptor (TCR) therapies. Its lead asset, iSCIB1+, is a DNA-based cancer vaccine entering second-half 2026 clinical trials. Plans Nasdaq listing via reverse merger with Neuphoria.